Synergistic inhibition of BCL-2 and CDK9 represents an effective therapy against hypodiploid B cell leukemia

Category
Webinar - Depertamento de Inmunología y Oncología
Date
Wednesday, 14 October 2020 16:00
Venue
Calle Darwin, 3, 28049 Madrid
Madrid, España
COM_ICAGENDA_PONENTE
Dr Ernesto Diaz-Flores . Pediatrics Oncology Department, School of Medicine, University of California, San Francisco
COM_ICAGENDA_CONTACTO
To attend this webinar, please contact the organizer Dra. Yolanda R. Carrasco
Telephone
91 585 48 52
Email